Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析

◆英語タイトル:Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1639
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sorrento Therapeutics Inc (SRNE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sorrento Therapeutics Inc (Sorrento), formerly QuikByte Software Inc, is a biopharmaceutical company. It focuses on developing therapeutics for the treatment of cancer, osteoarthritis pain as well as infectious and immunological related diseases. The company’s immuno-oncology (I-O) portfolio comprises of a broad fully human antibody library (G-MAB), clinical stage chimeric antigen receptor-T cells (CAR-T), antibody-drug conjugates (ADC), Dimeric Antigen Receptor T cells (DAR-T) and an oncolytic virus (Sephrehvir). It markets its only approved product, ZTlido (lidocaine topical system 1.8%), in the US for the treatment of postherpetic neuralgia (PHN). The company works in collaboration with biopharmaceutical companies and academic institutions to develop novel immunotherapies. Sorrento is headquartered in San Diego, California, the US.

Sorrento Therapeutics Inc Key Recent Developments

Apr 01,2020 Sorrento forms alliance for preclinical testing of Covid-19 drugs
Jan 29,2020 Sorrento and Celularity to initiate emergency Allogeneic Natural Killer (NK) Cell Therapy development for Coronavirus Infection

Dec 16,2019 Sorrento announces Dr. Robin Smith as new member of the Board of Directors
Dec 09,2019 Sorrento announces new board member

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sorrento Therapeutics Inc – Key Facts
Sorrento Therapeutics Inc – Key Employees
Sorrento Therapeutics Inc – Key Employee Biographies
Sorrento Therapeutics Inc – Major Products and Services
Sorrento Therapeutics Inc – History
Sorrento Therapeutics Inc – Company Statement
Sorrento Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Sorrento Therapeutics Inc – Business Description
Business Segment: Scilex
Overview
Performance
Business Segment: Sorrento Therapeutics
Overview
Performance
Sorrento Therapeutics Inc – Corporate Strategy
Sorrento Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Sorrento Therapeutics Inc – Strengths
Sorrento Therapeutics Inc – Weaknesses
Sorrento Therapeutics Inc – Opportunities
Sorrento Therapeutics Inc – Threats
Sorrento Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sorrento Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 01, 2020: Sorrento forms alliance for preclinical testing of Covid-19 drugs
Jan 29, 2020: Sorrento and Celularity to initiate emergency Allogeneic Natural Killer (NK) Cell Therapy development for Coronavirus Infection
Dec 16, 2019: Sorrento announces Dr. Robin Smith as new member of the Board of Directors
Dec 09, 2019: Sorrento announces new board member
Nov 12, 2019: Sorrento CEO to present at upcoming investor conferences
Apr 16, 2019: Sorrento establishes business unit to address market opportunity for proprietary water soluble cannabidiol formulations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sorrento Therapeutics Inc, Key Facts
Sorrento Therapeutics Inc, Key Employees
Sorrento Therapeutics Inc, Key Employee Biographies
Sorrento Therapeutics Inc, Major Products and Services
Sorrento Therapeutics Inc, History
Sorrento Therapeutics Inc, Subsidiaries
Sorrento Therapeutics Inc, Joint Venture
Sorrento Therapeutics Inc, Key Competitors
Sorrento Therapeutics Inc, Ratios based on current share price
Sorrento Therapeutics Inc, Annual Ratios
Sorrento Therapeutics Inc, Annual Ratios (Cont...1)
Sorrento Therapeutics Inc, Annual Ratios (Cont...2)
Sorrento Therapeutics Inc, Interim Ratios
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sorrento Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sorrento Therapeutics Inc, Performance Chart (2015 - 2019)
Sorrento Therapeutics Inc, Ratio Charts
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QuadraMed Corp-医療機器分野:企業M&A・提携分析
    Summary Quadramed Corporation (Quadramed) is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamlining processes, increase product …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sun Life Hong Kong Limited:企業の戦略・SWOT・財務分析
    Sun Life Hong Kong Limited - Strategy, SWOT and Corporate Finance Report Summary Sun Life Hong Kong Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • MediaCorp Pte Ltd:企業の戦略的SWOT分析
    MediaCorp Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Gannett Co., Inc.:戦略・SWOT・企業財務分析
    Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • National Rural Utilities Cooperative Finance Corporation:企業の戦略・SWOT・財務情報
    National Rural Utilities Cooperative Finance Corporation - Strategy, SWOT and Corporate Finance Report Summary National Rural Utilities Cooperative Finance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the comp …
  • Xcel Energy Inc (XEL):企業の財務・戦略的SWOT分析
    Xcel Energy Inc (XEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Weatherford International Ltd.:企業のM&A・事業提携・投資動向
    Weatherford International Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Weatherford International Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • IB Pharmaceuticals Inc (INNT):製薬・医療:M&Aディール及び事業提携情報
    Summary IB Pharmaceuticals Inc (IB Pharmaceuticals), formerly Innovate Biopharmaceuticals Inc, is a clinical-stage biotechnology company that discovers and develops novel medicines for orphan and gastroenterological disorders. The company’s pipeline includes INN-108 intended for inflammatory bowel d …
  • Lonestar Resources US Inc (LONE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lonestar Resources US Inc (Lonestar) is an independent oil and gas company that focuses on acquisition, exploration, development and production of oil and natural gas resources. Lonestar holds majority of the working interests in its properties and manages activities related to designing and …
  • Stemcor Global Holdings Ltd:企業の戦略・SWOT・財務情報
    Stemcor Global Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Stemcor Global Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Mallinckrodt plc:企業の戦略・SWOT・財務分析
    Mallinckrodt plc - Strategy, SWOT and Corporate Finance Report Summary Mallinckrodt plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Samsung Heavy Industries Co Ltd:戦略・SWOT・企業財務分析
    Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Reliable Ventures India Limited:戦略・SWOT・企業財務分析
    Reliable Ventures India Limited - Strategy, SWOT and Corporate Finance Report Summary Reliable Ventures India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • International Consolidated Airlines Group, S.A.:企業の戦略・SWOT・財務分析
    International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Volkswind GmbH-エネルギー分野:企業M&A・提携分析
    Summary Volkswind GmbH (Volkswind), a subsidiary of Axpo Holding AG, is an independent renewable power producer. It undertakes the planning, development, construction and operations of wind power plants. Volkswind builds wind farms with wind turbines from various suppliers including Seimens, Enercon …
  • Scope Metals Group Ltd:企業の戦略・SWOT・財務情報
    Scope Metals Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Scope Metals Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Multan Electric Power Co Ltd:企業の戦略的SWOT分析
    Multan Electric Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Metabolomic Diagnostics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Metabolomic Diagnostics Ltd (Metabolomic Diagnostics) is an early stage medical diagnostic company that develops technology to provide predictive diagnosis of pre-eclampsia in early pregnancy. The company uses metabolic profiling for investigating the low molecular weight biochemicals existi …
  • UbiVac LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary UbiVac LLC (UbiVac) is a clinical stage immuno-oncology companythat offers immunotherapeutic products. The company offers research and development of therapeutic vaccines for the treatment of cancer and infectious diseases. Its pipeline product includes DPV-001, a DC-targeted complex vaccine …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆